The beneficiary of the project is Centrum Medyczne Gizińscy Spółka z o.o. based in Bydgoszcz. The project is eligible for support under Priority Axis 6 Social solidarity and competitive staff, Measure 6.1 Investments in health and social infrastructure, Sub-measure 6.1.1 Investments in health infrastructure, Scheme: Improving the availability of diagnostic services within primary care and special outpatient care aimed at the development of coordinated care under the Regional Operational Program for the Kuyavian-Pomeranian Voivodeship for the years 2014-2020.
The total investment sum of the project amount to PLN 372,730.00 gross.
The EU contribution (EFRR) is PLN 186,365.00 gross.
The main objective of the project is to increase the availability of medical services and improve the quality of medical services provided in outpatient settings through the purchase of modern medical equipment in the field of surgery.
Project’s aim: Implementation of a world-class innovation service – minimally invasive endoscopic technique in spinal surgery in the treatment of spinal stenoses with the possibility of endoscopic denervation.
Widespread methods of treating the symptoms of spinal stenosis are pharmacological therapy or physical therapy. However, the best way to treat not only the symptoms but also the causes of spinal canal stenosis is bone decompression by means of laminectomy, central flavectomy or hemilaminectomy. In about 70% of cases, pharmacological treatment and physical therapy do not bring the desired effects, which makes it necessary to perform surgical treatment.
Basic disadvantages of the currently used solutions:
Long procedure time and the need to hospitalize the patient
Highly invasive characteristics of the operation
Significant violation of the structure of the tissues of the patient’s body
Greater traumatization of the skeletal system
Possibility of complications during the operation.
Basic advantages of the innovative service:
Shorter surgery time
Reduced hospitalization and recovery time
Less risk of infection
Less traumatization of the skeletal system
Smaller exposure of the patient and staff performing the procedure to X-rays during the procedure
Less postoperative pain – faster recovery
The material scope of the project includes the purchase of fixed assets: a lumbar set – laminar access, a set for stenoses with a set for blades, a set for endoscopic denervation / nucleoplasty, an irrigation pump for denervation with a set of reusable drains, radiothermia for neurosurgical procedures, a drive set for endoscopic surgical procedures spine, vision set – camera for endoscopy of the spine, set – trolley for endoscopic equipment.
The project is going to achieve the following indicators:
Number of enterprises receiving support (CI1) – 1
Number of enterprises receiving donations (CI2) – 1
Number of enterprises supported in the field of eco-innovation – 1
Private investments supplementing public support for enterprises (subsidies) (CI6) – PLN 242,336.04
Number of enterprises covered by support in order to introduce products new to the market (CI 28) – 1
Number of introduced product innovations – 1
Increase in employment in supported enterprises (CI8) – 3.00 FTE
Revenue from the sale of new or improved products / services –
Project value: PLN 742,336.04
Contribution of European Funds: PLN 500,000.00
Centrum Medyczne Gizinscy Sp. z o. o. implements a project co-financed from European Funds Agreement No.: POIR.03.04.00-04-0387/20-00 Working capital subsidy for Centrum Medyczne Gizińscy sp. z o.o., under Measure 3.4 Working capital subsidies of the Smart Growth Operational Program 2014-2020, co-financed by the European Regional Development Fund.
The project concerns support for the entrepreneur in ensuring financial liquidity and support for current operations in connection with the financial difficulties that the entrepreneur experienced as a result of the COVID-19 epidemic. Financial assistance provided under the program No. SA.57015 (2020/N).
The material and financial scope of the project assumes the maintenance of the company’s operations.
Project value: PLN 267,412.44
Contribution of European Funds: PLN 267,412.44
Centrum Medyczne Gizińscy Sp. z o.o. implements a project entitled “Establishment of the Research and Development Center of Centrum Medyczne Gizińscy – Center for research in the field of diagnostics and new algorithms for the treatment of drug-resistant and serious mental disorders requiring chronic treatment” under the POIR.02.01.00-00-0189/19-01 agreement under the Operational Program Smart Growth, Priority Axis II: Support for the environment and potential of enterprises to conduct R&D activities, Measure 2.1. Support for investments in R&D infrastructure of enterprises
The aim of the project is to create a Research and Development Center, including modern diagnostics and treatment in the field of psychiatry.
Planned effects: Innovative treatment procedures:
drug-resistant depression with the use of dTMS, enabling the optimization of the treatment process of severe, chronic mood disorders that have not responded to the treatment methods used so far.
obsessive-compulsive disorder (OCD) with the use of dTMS, enabling optimization of the treatment process of severe, chronic anxiety disorders that have not responded to the treatment methods used so far.
anorexic eating disorders (anorexia nervosa; AN) with the use of dTMS to optimize the process
treatment of chronic eating disorders that have not responded to previous treatment.
drug-resistant depression with the use of electroconvulsive therapy and augmentation of ketamine treatment as a method that increases the effectiveness of electroconvulsive therapy (ECT) and reduces the risk of cognitive disorders associated with ECT – to enable optimization of the treatment process of severe, chronic mood disorders that have not responded to the treatment used so far. Also, the development of standards for the regular use of an innovative treatment procedure for drug-resistant depression with the use of vagus nerve stimulation (VNS – vagus nerve stimulation), enabling the optimization of the treatment process of severe, chronic mood disorders that have not responded to the treatment used so far.
Total value of the project: 19,500,000.00 PLN
Value of co-financing from the EU: 8,775,000.00 PLN